Being diagnosed with rectal cancer can be emotionally and physically challenging for patients.
Patients often worry about:
The good news is that rectal cancer treatment has changed dramatically over the last decade.
Modern treatment is no longer based only on where the cancer is located. Today, doctors also study the biology of the cancer, its genetic profile, and its response to treatment to develop a personalized treatment strategy.
At Ravi’s American Cancer Care in Vijayawada, we combine advanced surgical oncology, medical oncology, molecular diagnostics, Next Generation Sequencing (NGS), liquid biopsy technology, and multidisciplinary treatment planning to provide state-of-the-art rectal cancer care.
A Modern Precision Oncology Approach
Patients have access to:
"Modern rectal cancer treatment is not defined by a single treatment or machine. The best outcomes come from careful staging, multidisciplinary planning, precision surgery, personalized medical oncology, and molecular-guided decision-making."
The rectum is the last segment of the large intestine, positioned just above the anal opening.
Rectal cancer develops when abnormal cells grow uncontrollably within the rectal lining.
Although rectal cancer is often grouped together with colon cancer under the term "colorectal cancer," rectal cancer is a distinct disease that often requires different treatment planning and surgical approaches.
Because of its location deep within the pelvis, treatment requires careful planning and specialized expertise.
Common symptoms may include:
Persistent symptoms should never be ignored.
When rectal cancer is detected early, treatment options are often broader and outcomes may be significantly improved.
Early diagnosis may:
Accurate staging is one of the most critical steps in planning rectal cancer treatment.
Unlike many cancers, rectal cancer treatment decisions often depend heavily on MRI findings.
MRI helps doctors understand:
Accurate staging helps ensure that each patient receives the most appropriate treatment plan.
Two patients may have rectal cancers that appear similar but behave very differently biologically.
Some tumors respond exceptionally well to treatment.
Others may require a different approach.
This is why modern oncology increasingly relies on molecular testing and precision medicine.
The future of cancer care is not simply identifying where the cancer is located—it is understanding the biology of the cancer itself.
Surgery remains one of the most important treatments for rectal cancer.
The goals of surgery include:
Because rectal surgery is performed within the narrow confines of the pelvis, precision is essential.
At Ravi’s American Cancer Care, selected procedures may utilize the Stryker 1788 platform and SPY-PHI fluorescence-guided imaging technology.
These advanced technologies provide:
Modern surgical oncology is not simply about removing cancer.
It is about operating with greater precision, improved visualization, and enhanced decision-making.
After the diseased portion of the rectum is removed, surgeons reconnect healthy bowel segments.
Successful healing depends heavily on adequate blood supply.
SPY-PHI fluorescence imaging helps assess tissue perfusion in real time during selected procedures.
This additional information may help surgeons optimize conditions for healing and support surgical planning.
One of the most common concerns among rectal cancer patients is the possibility of a permanent colostomy bag.
The answer depends on:
Whenever safely possible, modern rectal cancer treatment aims to preserve normal bowel function.
Treatment decisions are individualized for every patient.
Modern medical oncology extends far beyond traditional chemotherapy.
Today's treatment options may include:
Choosing the right treatment requires understanding the molecular characteristics of the cancer.
Next Generation Sequencing (NGS) studies the genetic blueprint of cancer cells.
Think of NGS as reading the cancer’s instruction manual.
NGS may help identify:
This information may influence:
At Ravi’s American Cancer Care, advanced NGS testing is available in Vijayawada to support precision oncology.
Certain rectal cancers demonstrate molecular features such as:
These patients may be candidates for immunotherapy.
Immunotherapy has transformed treatment possibilities for selected patients by helping the immune system recognize and attack cancer cells.
One of the most exciting developments in modern oncology is liquid biopsy.
Instead of relying only on tissue samples, liquid biopsy analyzes tiny fragments of tumor DNA circulating in the bloodstream.
Doctors can collect essential information through a minimally invasive blood test.
Even after successful treatment, microscopic traces of cancer may sometimes remain in the body.
These cells may be too small to appear on scans.
Using advanced liquid biopsy technology, circulating tumor DNA (ctDNA) may sometimes detect molecular evidence of residual disease before recurrence becomes visible on imaging.
MRD assessment may help:
This represents one of the most advanced applications of precision oncology available today.
Successful treatment extends beyond surgery and medications.
Modern cancer care also focuses on:
Many patients return to active and productive lives following treatment.
Patients diagnosed with:
may benefit from specialized oncology review and personalized treatment planning.
A second opinion may help clarify:
Is rectal cancer different from colon cancer?
Yes. Although both are forms of colorectal cancer, rectal cancer often requires different treatment planning because of its location within the pelvis.
Can rectal cancer be cured?
Many rectal cancers can be treated successfully, particularly when diagnosed early.
Will I need a permanent colostomy?
Not every patient requires a permanent colostomy. Treatment decisions depend on tumor location, stage, and response to treatment.
Is NGS testing important in rectal cancer?
NGS may provide important molecular information that can help guide personalized treatment decisions.
What is liquid biopsy?
Liquid biopsy analyzes tumor DNA circulating in the bloodstream and may assist with monitoring and treatment planning.
Is immunotherapy useful for rectal cancer?
Selected patients with MSI-High or dMMR tumors may benefit significantly from immunotherapy.
The future of rectal cancer care is not one-size-fits-all treatment.
It is precision medicine.
By combining advanced surgery, high-definition surgical imaging, fluorescence-guided technology, molecular diagnostics, NGS, liquid biopsy, MRD testing, immunotherapy, and personalized treatment planning, modern rectal cancer care is becoming more precise than ever before.
“The future of cancer care lies in delivering the right treatment rather than simply increasing the amount of treatment. It is smarter treatment.”
Ravi’s American Cancer Care
Kaleswara Rao Road, opposite Pushpa Hotel Bus Stop, Suryaraopeta, Vijayawada – 520002
+91 8889996108